title: High-resolution deletion mapping of chromosome arm 17p in childhood primitive neuroectodermal tumors reveals a common chromosomal disruption within the Smith-Magenis region, an unstable region in chromosome band 17p11.2.
abstract: Loss of heterozygosity (LOH) on chromosome arm 17p is the most common genetic aberration in childhood primitive neuroectodermal tumors (PNETs). To determine the frequency and extent of 17p deletions, 29 loci on 17p were investigated in 24 tumors by using restriction fragment length polymorphism (RFLP) and microsatellite analysis. LOH on 17p was found in 9 of 24 tumors. In all tumors with LOH, a continuous stretch from the telomere to chromosome band 17p11.2 was completely deleted, and no interstitial or terminal small-scale deletions were detected in the remaining 15 tumors. In four tumors with LOH on 17p, the chromosomal breakpoint was located between D17S953 and D17S805. To identify this deletion breakpoint on the cytogenetic map of chromosome 17 and to exclude uniparental disomy, we verified our data by using fluorescence in situ hybridization (FISH) analyses. By using two yeast artificial chromosome (YAC) clones that were positive for D17S689 and D17S953, the same breakpoint was confirmed in two specimens of cerebrospinal fluid (CSF) metastases by using FISH on interphase preparations. We demonstrate that, in most childhood PNETs with LOH on 17p, the breakpoint is close to, but not within, the centromere. It varies, and it occurs predominantly between the two markers D17S689 and D17S953, which is an unstable chromosomal region that is deleted or duplicated in the Smith-Magenis syndrome. Because LOH of 17p is associated with the formation of isochromosome 17q in the majority of PNETs, this study provides entry points to determine the molecular nature of this phenomenon.
authors.affiliation: Department of Pediatrics, University of Würzburg, Germany.
authors.forename: W G
authors.initials: WG
authors.lastname: Scheurlen
authors.forename: P
authors.initials: P
authors.lastname: Seranski
authors.forename: A
authors.initials: A
authors.lastname: Mincheva
authors.forename: J
authors.initials: J
authors.lastname: Kühl
authors.forename: N
authors.initials: N
authors.lastname: Sörensen
authors.forename: J
authors.initials: J
authors.lastname: Krauss
authors.forename: P
authors.initials: P
authors.lastname: Lichter
authors.forename: A
authors.initials: A
authors.lastname: Poustka
authors.forename: K K
authors.initials: KK
authors.lastname: Wilgenbus
mesh_terms: D000293:Adolescent; D000328:Adult; D001932:Brain Neoplasms / Q000134:cerebrospinal fluid / Q000235:genetics*; D002648:Child; D002675:Child, Preschool; D002869:Chromosome Aberrations; D002872:Chromosome Deletion; D002874:Chromosome Mapping; D002886:Chromosomes, Human, Pair 17; D004273:DNA, Neoplasm / Q000032:analysis; D005260:Female; D017353:Gene Deletion; D016147:Genes, Tumor Suppressor; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D007399:Interphase; D008297:Male; D008677:Metaphase; D018895:Microsatellite Repeats; D017599:Neuroectodermal Tumors / Q000134:cerebrospinal fluid / Q000235:genetics*; D012150:Polymorphism, Restriction Fragment Length
chemical_list: D004273:DNA, Neoplasm